These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: The interaction of calmodulin with human erythrocyte spectrin. Inhibition of protein 4.1-stimulated actin binding.
    Author: Anderson JP, Morrow JS.
    Journal: J Biol Chem; 1987 May 05; 262(13):6365-72. PubMed ID: 3571263.
    Abstract:
    The functional significance of calmodulin binding to human erythrocyte spectrin has been investigated under native conditions. Both native calmodulin and calmodulin derivatized with the photoactivable cross-linker methyl 4-azidobenzimidate (azidocalmodulin) have been used. When azidocalmodulin is photolyzed in the presence of erythrocyte ghosts, ghost extracts, or purified protein, it cross-links predominately to the beta subunit of erythrocyte spectrin. This cross-linking is calcium-dependent, requires photolysis, and is inhibited by 100 microM trifluoperazine or unlabeled calmodulin. Calmodulin labeled spectrin exhibits a specific and non-calcium-dependent inhibition of its ability to bind actin, even in the presence of protein 4.1. Its ability to self-associate or to bind spectrin-depleted membrane vesicles is unperturbed. Native calmodulin also inhibits protein 4.1-stimulated spectrin-actin binding, but unlike that of covalently bound calmodulin, inhibition by the uncross-linked calmodulin requires calcium. The degree of inhibition of spectrin-actin-4.1 binding induced by native calmodulin is significant since 109 microM calmodulin inhibits over 63% of the spectrin-actin binding induced by 4.5 microM protein 4.1. These results demonstrate a specific effect of calmodulin on erythroid spectrin function and suggest that calmodulin may influence the binding of protein 4.1 and actin to spectrin within the cytoskeleton.
    [Abstract] [Full Text] [Related] [New Search]